| (S)-nicotine | increases expression | ISO | RGD:1606034 | 6480464 | Nicotine results in increased expression of HINT1 mRNA | CTD | PMID:20514075 |
| (S)-nicotine | multiple interactions | ISO | RGD:1317233 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HINT1 mRNA; more ... | CTD | PMID:20230807 |
| (S)-nicotine | increases expression | ISO | RGD:1317233 | 6480464 | Nicotine results in increased expression of HINT1 protein | CTD | PMID:20514075 |
| (S)-nicotine | multiple interactions | ISO | RGD:1317233 | 6480464 | Mecamylamine inhibits the reaction [Nicotine results in increased expression of HINT1 protein] | CTD | PMID:20514075 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:1317233 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HINT1 mRNA; more ... | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | ISO | RGD:1317233 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of HINT1 mRNA | CTD | PMID:20230807 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1317233 | 6480464 | Ethinyl Estradiol affects the expression of HINT1 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1317233 | 6480464 | Ethinyl Estradiol results in increased expression of HINT1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1317233 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HINT1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1317233 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HINT1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1317233 | 6480464 | Tetrachlorodibenzodioxin affects the expression of HINT1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HINT1 protein | CTD | PMID:15822908 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1317233 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of HINT1 mRNA | CTD | PMID:18648102 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1606034 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of HINT1 mRNA | CTD | PMID:12419474 |
| 5-fluorouracil | increases expression | ISO | RGD:1606034 | 6480464 | Fluorouracil results in increased expression of HINT1 protein | CTD | PMID:15585135 PMID:16803524 |
| 5-fluorouracil | increases expression | ISO | RGD:1606034 | 6480464 | Fluorouracil results in increased expression of HINT1 protein | CTD | PMID:16803524 PMID:15585135 |
| amphetamine | affects response to substance | ISO | RGD:1317233 | 6480464 | HINT1 protein affects the susceptibility to Amphetamine | CTD | PMID:17203012 |
| aniline | increases expression | ISO | RGD:1317233 | 6480464 | aniline results in increased expression of HINT1 mRNA | CTD | PMID:22016648 |
| atrazine | multiple interactions | ISO | RGD:1606034 | 6480464 | [Atrazine co-treated with Arsenates] results in increased expression of HINT1 mRNA | CTD | PMID:18585445 |
| benzene | increases expression | ISO | RGD:1317233 | 6480464 | Benzene results in increased expression of HINT1 mRNA | CTD | PMID:15122651 PMID:15120971 |
| benzene | increases expression | ISO | RGD:1317233 | 6480464 | Benzene results in increased expression of HINT1 mRNA | CTD | PMID:15120971 PMID:15122651 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of HINT1 mRNA | CTD | PMID:21839799 |
| benzo[a]pyrene | increases expression | ISO | RGD:1606034 | 6480464 | Benzo(a)pyrene results in increased expression of HINT1 mRNA | CTD | PMID:21714911 |
| caffeine | multiple interactions | ISO | RGD:1317233 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HINT1 mRNA; more ... | CTD | PMID:20230807 |
| diethylstilbestrol | increases expression | ISO | RGD:1606034 | 6480464 | Diethylstilbestrol results in increased expression of HINT1 mRNA | CTD | PMID:15766595 |
| disodium selenite | increases expression | ISO | RGD:1606034 | 6480464 | Sodium Selenite results in increased expression of HINT1 mRNA | CTD | PMID:18175754 |
| doxorubicin | increases expression | ISO | RGD:1317233 | 6480464 | Doxorubicin results in increased expression of HINT1 mRNA | CTD | PMID:22016648 |
| hydralazine | multiple interactions | ISO | RGD:1606034 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of HINT1 mRNA | CTD | PMID:17183730 |
| hydrogen peroxide | decreases expression | ISO | RGD:1606034 | 6480464 | Hydrogen Peroxide results in decreased expression of HINT1 mRNA | CTD | PMID:12419474 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1606034 | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of HINT1 protein | CTD | PMID:18951874 |
| lovastatin | increases expression | ISO | RGD:1317233 | 6480464 | Lovastatin results in increased expression of HINT1 mRNA | CTD | PMID:20493250 |
| morphine | multiple interactions | ISO | RGD:1317233 | 6480464 | HINT1 affects the reaction [Morphine promotes the reaction [OPRM1 protein binds to MAPK1 protein]]; more ... | CTD | PMID:21235400 |
| morphine | increases response to substance | ISO | RGD:1317233 | 6480464 | HINT1 gene mutant form results in increased susceptibility to Morphine | CTD | PMID:18652891 |
| morphine | multiple interactions | ISO | RGD:1317233 | 6480464 | HINT1 gene mutant form inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCA protein]]; more ... | CTD | PMID:18652891 |
| paracetamol | affects expression | ISO | RGD:1317233 | 6480464 | Acetaminophen affects the expression of HINT1 mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:1606034 | 6480464 | Acetaminophen results in decreased expression of HINT1 mRNA | CTD | PMID:21420995 |
| pyrogallol | increases expression | ISO | RGD:1317233 | 6480464 | Pyrogallol results in increased expression of HINT1 mRNA | CTD | PMID:20362636 |
| rotenone | increases expression | ISO | RGD:1317233 | 6480464 | Rotenone results in increased expression of HINT1 mRNA | CTD | PMID:22016648 |
| sulfasalazine | increases expression | ISO | RGD:1317233 | 6480464 | Sulfasalazine results in increased expression of HINT1 mRNA | CTD | PMID:22016648 |
| tamoxifen | affects expression | ISO | RGD:1317233 | 6480464 | Tamoxifen affects the expression of HINT1 mRNA | CTD | PMID:17555576 |
| theophylline | multiple interactions | ISO | RGD:1606034 | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of HINT1 protein | CTD | PMID:18951874 |
| valproic acid | multiple interactions | ISO | RGD:1606034 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of HINT1 mRNA | CTD | PMID:17183730 |
| valproic acid | affects expression | ISO | RGD:1317233 | 6480464 | Valproic Acid affects the expression of HINT1 mRNA | CTD | PMID:17292431 |
| zinc atom | multiple interactions | ISO | RGD:1317233 | 6480464 | Zinc promotes the reaction [RAF1 protein binds to PRKCG protein binds to HINT1 protein] | CTD | PMID:21235400 |
| zinc(0) | multiple interactions | ISO | RGD:1317233 | 6480464 | Zinc promotes the reaction [RAF1 protein binds to PRKCG protein binds to HINT1 protein] | CTD | PMID:21235400 |